PSIL
AdvisorShares Psychedelics ETF · PSE
- Category Health Care
- Expense Ratio 0.99%
- Listing Date Sep 16, 2021
- Volume 3,664.0
- Market Cap (AUM) $6.0M
Performance
-1.48%
1W
-11.62%
1M
+32.96%
3M
+1.6%
6M
-22.52%
YTD
-18.8%
1Y
Top Holdings
-
Name
Symbol%Assets
- Mind Medicine (MindMed), Inc.MNMD15.20%
- Cybin, Inc.CYBN8.40%
- COMPASS Pathways Plc Sponsored ADRCMPS6.50%
- MUTUAL FUND (OTHER)N/A6.13%
- Intra-Cellular Therapies, Inc.ITCI5.50%
- GH Research PlcGHRS5.50%
- Alkermes Public Limited CompanyALKS5.21%
- Relmada Therapeutics IncRLMD5.14%
- NRX Pharmaceuticals, Inc.NRXP4.80%
- ATAI Life Sciences N.V.ATAI4.78%
Technical Analysis of PSIL 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-15 04:20
No Trippin: Trump Trade Pushes PSIL, VCAR Higher(Yahoo Finance)
- 2024-08-30 16:15
AdvisorShares Announces Reverse Split of ETF(PR Newswire)
- 2024-08-30 04:15
AdvisorShares Announces Reverse Split of ETF(Prnewswire)
- 2022-08-23 20:42
- 2022-04-03 22:30
Best & Worst Performing ETFs Of 2022(Yahoo Finance)
- 2022-02-01 01:30
3rd Psychedelics ETF Launches(Yahoo Finance)
- 2021-11-03 02:15
ETFs & Innovation Go Hand In Hand(Yahoo Finance)
- 2021-10-17 20:35
- 2021-09-30 19:30
- 2021-09-22 19:30
- 2021-09-20 21:45
- 2021-09-19 19:50
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.